TCL Archive Also in this 8-page issue: NCI advisors approve $15-million set-aside for laboratory testing on “reduced harm” tobacco products. July 9, 2004
TCL Archive Also von Eschenbach Role in Industry Program Raises New Concerns of Conflict of Interest. November 22, 2006
TCL Archive New Phase III Trial Reviews Approve 25%; Should Trialists Worry? Not Yet, January 19, 2007
TCL Archive NCI Moves Ahead With Trials Database, Reporting Studies In Progress At Cancer Centers July 15, 2011
